Fondazione Irccs Istituto Nazionale Dei Tumori, Milano
Clinical trials sponsored by Fondazione Irccs Istituto Nazionale Dei Tumori, Milano, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New trial combines drugs with surgery or radiation to fight advanced prostate cancer Results expected Jan 2027 (estimated)
- Blood test may reveal hidden tumor secrets in head and neck cancer Results expected Jul 2027 (estimated)
-
Drug combo may stop opioids from making pain worse after surgery
Symptom relief CompletedThis study tested whether giving ketamine during surgery and methadone after surgery can prevent a condition called opioid-induced hyperalgesia, where painkillers actually make pain worse. 113 patients having open colorectal surgery took part. Researchers measured the area of inc…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
App aims to catch Quality-of-Life drops early in head and neck cancer survivors
Knowledge-focused CompletedThis completed trial tested a mobile app and web platform (BD4QoL) to monitor quality of life in 410 head and neck cancer survivors after curative treatment. The goal was to see if the platform could reduce or catch early declines in quality of life compared to standard follow-up…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Desmoid tumor study: is doing nothing the best medicine?
Knowledge-focused CompletedThis study looked at 100 people with desmoid tumors (a rare, non-cancerous growth) to see what happens when doctors don't treat them right away. Instead, patients were monitored closely with scans, and treatment only started if the tumor grew. The goal was to learn how often thes…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:31 UTC